Treatment and Survival for Unresectable Pancreatic Adenocarcinoma in Queensland, Australia, 2018–2022
Apart from clinical indications, there should be equity in the treatment received for unresectable pancreatic cancer. Our results suggest, however, that where a person lives and the type of facility at which they are treated may influence their chemotherapy regimen.
Authors
- Michael J. Allen (ORCID: https://orcid.org/0000-0001-5091-5995)
- Bryan Chan (ORCID: https://orcid.org/0000-0002-6492-1197)
- Danny R. Youlden (ORCID: https://orcid.org/0000-0002-2721-9083)
- Jon D. Clark
- Veronica Donoghue
Institutions
- Griffith University (AU)
- University of the Sunshine Coast (AU)
- Metro South Health (AU)
- Sunshine Coast University Hospital (AU)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/cam4.71226
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Griffith University